Treatment failure was prominent among adults with type 2 diabetes (T2D) that initiated treatment of sodium-glucose cotransporter 2 inhibitors (SGLT2is), according to a study in Diabetes & Metabolic Syndrome: Clinical Research & Reviews.1 Highlighting... [5994 chars].. reed more
